Hematopoiesis News 7.25 June 28, 2016 | |
| |
TOP STORYResearchers Discover How Faulty Genetic Instructions Drive a Deadly Blood Cancer in Adults Researchers discovered how a set of faulty genetic instructions keep blood stem cells from maturing, a finding that further explains the development of AML. They revealed how a mutation in the gene DNMT3A, which has been found in approximately 20 to 30 percent of cases of AML, gives normal cells faulty genetic instructions that contribute to the development of cancerous cells. [Press release from University of North Carolina at Chapel Hill discussing online prepublication in Cancer Cell] Press Release | Abstract | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)To address the impact of cellular origin on acute myeloid leukemia (AML), researchers generated an inducible transgenic mouse model for MLL-AF9-driven leukemia. MLL-AF9 expression in long-term hematopoietic stem cells in vitro resulted in dispersed clonogenic growth and expression of genes involved in migration and invasion. [Cancer Cell] Abstract | Press Release Researchers report a critical role for the p38MAPK family isoform p38α in initiating hematopoietic stem and progenitor cell proliferation during stress hematopoiesis in mice. [Cell Stem Cell] Abstract | Graphical Abstract MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML Scientists demonstrated that MEIS2 is expressed at high levels in patients with AML1-ETO-positive acute myeloid leukemia and that growth of AML1-ETO-positive leukemia depends on MEIS2 expression. [Cell Rep] Full Article | Graphical Abstract Recently, a new and recurrent juxtamembrane deletion mutation (p.Q569Vfs*2) resulting in a truncated receptor was identified. The mutated receptor was expressed on the cell surface and still binds its ligand but lost the ability to activate ERK signaling. Fms-like tyrosine kinase 3 (FLT3) p.Q569fs-expressing Ba/F3 cells showed no proliferation after ligand stimulation. [Sci Rep] Full Article The effects of silicon nanoparticles (SiNPs) on hemocytes and hematopoiesis were investigated by administering SiNPs via a vascular injection into an invertebrate model, the silkworm. [Chemosphere] Abstract Researchers developed a lentiviral vector able to overexpress Coq9 mRNA and COQ9 protein in mouse embryonic fibroblasts and hematopoietic progenitor cells from Coq9R239X mice, an animal model of mitochondrial encephalopathy due to primary coenzyme Q deficiency. [PLoS One] Full Article CLINICAL RESEARCHInvestigators report a cohort of 19 consecutive patients with acute leukemias and non-malignant diseases who experienced graft failure after previous hematopoietic stem cell transplantation from matched or haploidentical donors between 2003 and 2012. [Br J Haematol] Abstract Investigators analyzed hematopoietic progenitor cell mobilization outcomes in lymphoma patients undergoing chemo-mobilization with ifosfamide, carboplatin and etoposide (ICE) compared with either routine plerixafor or “just in time” plerixafor based mobilization [Biol Blood Marrow Transplant] Abstract | |
| |
REVIEWSHemoglobin Genetics: Recent Contributions of GWAS and Gene Editing Although the principal erythroid cell transcription factors are known, mechanisms responsible for silencing of the γ-globin gene were obscure until application of genome-wide association studies (GWAS). The authors review findings in the field [Hum Mol Genet] Abstract Visit our reviews page to see a complete list of reviews in the hematopoiesis research field.
| |
INDUSTRY NEWSUnum Therapeutics announced that the IND application for ACTR087 for the treatment of adult patients with relapsed/refractory CD20-positive B-cell non-Hodgkin lymphoma, is now active. [Unum Therapeutics] Press Release GlycoMimetics, Inc. announced dosing of the first patient with newly diagnosed acute myeloid leukemia (AML) in the Phase II portion of its ongoing Phase I/II study evaluating its novel E-selectin antagonist, GMI-1271, combined with chemotherapy. In addition, GlycoMimetics recently announced that the first patient with relapsed or refractory AML has been dosed in the other arm of the Phase II portion of this study. [GlycoMimetics, Inc.] Press Release The Re-Programmer: Qian Receives Global Award for Stem Cell Research The 36-year-old assistant professor at University of Northern Carolina School of Medicine’s Department of Pathology and Laboratory Medicine has been recognized internationally for her scientific developments in cellular reprogramming and stem cell research. Qian is the first-ever recipient of the Boyalife, Science and Science Translational Medicine Award in Stem Cell and Regenerative Medicine. [University of Northern Carolina] Press Release | |
From our sponsor: Learn about detecting cancer stem cells with ALDEFLUORâ„¢. Watch the webinar.
| |
EVENTSNEW 34th International Congress of the International Society of Blood Tranfusion (ISBT) Visit our events page to see a complete list of events in the hematopoiesis community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Fellow – Tumor Microenvironment and Cancer Stem Cells (Duke University) Scientist – Hematology (STEMCELL Technologies Inc.) Technical Sales Representative (STEMCELL Technologies Inc.) Postdoctoral Fellow – Characterizing and Targeting Cancer Stem Cells (City of Hope) Cytogenetics Laboratory Supervisor (Fred Hutchinson Cancer Research Center) Postdoctoral Fellow – Hematopoietic Stem Cell Biology (Novartis) Research Assistants and Associates – Leukemia and Stem Cell Biology (King’s College London) Postdoctoral Research Associate – Myeloid Leukemia (Upstate Medical University) Postdoctoral Fellow – Leukemia Lymphoma (Emory University) Research Technician – Hematopoietic Stem Cell Biology (Fred Hutchinson Cancer Research Center) Postdoctoral Fellow – Hematology/Oncology (Boston Children’s Hospital) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Hematopoiesis News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|
Home Hematopoiesis News Volume 7.25 | Jun 28 2016